Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alternativeName |
GSK-8341
|
| gptkbp:canBe |
treatment of type 2 diabetes
|
| gptkbp:CASNumber |
1441674-54-6
|
| gptkbp:developedBy |
GlaxoSmithKline
|
| gptkbp:drugClass |
gptkb:GLP-1_receptor_agonist
|
| gptkbp:hasMolecularFormula |
C20H19ClN4O2S
|
| gptkbp:status |
gptkb:investigational_drug
|
| gptkbp:bfsParent |
gptkb:GDM_series
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
GDM-8341
|